Inhibition of cancer procoagulant
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 29, 1993
Issued Date -
N/A
app pub date -
Jun 28, 1991
filing date -
Nov 1, 1988
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Peptidyl inhibitors, for example, peptidyl diazomethyl ketones and peptidyl methylsulfonium salts wherein the peptidyl moiety comprises two to ten amino acid residues inhibit cancer procoagulant, a cysteine proteinase, that is necessary for the viability of malignant cells. This invention provides for methods of cancer therapy and blood detoxification wherein these peptidyl inhibitors are used to destroy malignant cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully